Effects of VALsartan On atRIAl Mitral Regurgitation

NCT07539298 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Atrial Functional Mitral Regurgitation

Interventions

DRUG: Valsartan
DRUG: Placebo

Sponsor

Jonathan Beaudoin

Collaborators

[object Object]
[object Object]